Integrating tuberculosis and HIV services for people living with HIV: Costs of the Zambian ProTEST Initiative

Cost Effectiveness and Resource Allocation

Volumn 6, Issue , 2008, Pages

  Terris Prestholt, Fern ^a   Kumaranayake, Lilani ^a   Ginwalla, Rokaya ^b   Ayles, Helen ^a,b   Kayawe, Ignatius ^c   Hillery, Mary ^d   Godfrey Faussett, Peter ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Anatomy Department   (Zambia)

^c Kara Counselling and Training Trust   (Zambia)

^d Archdiocese of Lusaka ^*  (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG COST; ECONOMIC ASPECT; FEASIBILITY STUDY; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH SERVICE; HOME CARE; HOSPICE CARE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; PATIENT CARE; PATIENT COUNSELING; SCREENING TEST; TUBERCULOSIS; URBAN AREA; ZAMBIA;

EID: 40749128884     PISSN: None     EISSN: 14787547     Source Type: Journal    
DOI: 10.1186/1478-7547-6-2     Document Type: Article

References (53)

1. UNAIDS Report on the global HIV/AIDS epidemic Geneva, UNAIDS; 2005.
2. The U.S. President's Emergency Plan for AIDS Relief Keeping the Promise to Support Treatment http://www.state.gov/s/gac/rl/fs/57505.htm
3. The Global Fund How the Fund Works http://www.theglobalfund.org/en/about/ how/
4. Bill & Melinda Gates Foundation HIV/AIDS http://www.gatesfoundation.org/GlobalHealth/Pri_Diseases/HIVAIDS/ default.htm
5. Godfrey-Faussett P Maher D Mukadi YD Nunn P Perriens J Raviglione M How human immunodeficiency virus voluntary testing can contribute to tuberculosis control Bulletin of the World Health Organization 2002, 80(12):939-945. 12571721
6. Mugisha B Bock N Mermin J Odeke RM Miller B Adatu-Engwau F Granich R Bunnell R Tuberculosis case finding and preventive therapy in an HIV voluntary counseling and testing center in Uganda. Int J Tuberc Lung Dis 2006, 10(7):761-767. 16848338
7. Wegbreit J Bertozzi S DeMaria LM Padian NS Effectiveness of HIV prevention strategies in resource-poor countries: Tailoring the intervention to the context AIDS 2006, 20(9):1217-1235. 10.1097/ 01.aids.0000232229.96134.56
8. Voluntary HIV-1 Counselling and Testing Efficacy Study Group Efficacy of voluntary HIV-a Counseling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: A randomised controlled trial Lancet 2000, 356:103-112. 10.1016/S0140-6736(00)02446-6 10963246
9. Kamenga M Ryder R Jingu M Mbuyi N Mbu L Behets F et al. Evidence of merked sexual behaviour change associated with low HIV-a seroconversion in 149 married couples with discourdant HIV-1 serostatus: Experience at an HIV counselling centre in Zaire AIDS 1991, 5:61-67. 2059362
10. Allen S Meinzen-Derr J Kautzman M Zulu I Trask S Fideli U et al. Sexual behavior of HIV discordant couples after HIV counseling and testing AIDS 2003, 17:733-740. 10.1097/00002030-200303280-00012 12646797
11. Burgess AL Fitzgerald DW Severe P Joseph P Noel E Rastogi N Johnson WD Jr. Pape JW Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti AIDS 2001, 15(14):1875-1879. 10.1097/00002030-200109280-00018 11579251
12. Bucher HC Griffith LE Guyatt GH Sudre P Naef M Sendi P Battegay M Isoniazid prophylaxis for tuberculosis in HIV infection: A meta-analysis of randomized controlled trials AIDS 1999, 13(4):501-507. 10.1097/ 00002030-199903110-00009 10197379
13. Wilkinson D Squire SB Garner P Effect of preventive treatment for tuberculosis in adults infected with HIV: Systematic review of randomised placebo controlled trials BMJ 1998, 317(7159):625-629. 28654 9727988
14. Whalen C Johnson J Okwera A Hom D Heubner R Muggyenyi P Mugerwa R A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus N Engl J Med 1997, 337(12):801-808. 10.1056/NEJM199709183371201 9295239
15. Johnson J Okwera A Hom D Mayanja H Kityo C Nsubuga P Nakibali J Duration efficacy of treatment of latent tuberculosis infection in HIV-infected adults AIDS 2001, 15:2137-2147. 10.1097/00002030-200111090-00009 11684933
16. Halsey N Coberly J Desormeaux J Losikoff P Atkinson J Moulton L Contave M Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-infection Lancet 1998, 351:786-792. 10.1016/S0140-6736(97)06532-X 9519950
17. World Health Organisation Global Programme on AIDS Review of six HIV/ AIDS programmes in Uganda and Zambia Geneva, World Health Organisation Global Programme on AIDS 1989
18. Ndyanabangi B Nyakahuma G Sahmueller G Evaluation of home-based care services to caregivers in Kabarole District, Western Uganda: May 24-27; Montreal, Canada. 1995
19. MacNiel J Anderson S Beyond the dichotomy: Linking HIV prevention with care AIDS 1998 12(suppl 2):S19-S26. 9792358
20. Kaleeba N Kalibala S Kaseje M Ssebbanja P Andersen S van Praag E Tembo G Katabira E Participatory evaluation of counseling, medical and social services of the AIDS Support Organization (TASO) in Uganda Geneva, Joint United Nations Programme on HIV/AIDS; 1997.
21. Family Health International Making prevention work: Global lessons learned from AIDS control and prevention (AIDSCAP) Project 1991-1997 Arlington, VA. USA, Family Health International; 1997.
22. Chela CM Siankanga ZC Home and community care: The Zambia experience AIDS 1991, 5(Suppl 1):S157-61. 1669913
23. Walker M Aceng E Tidyebwa D Nabyonga J Ogwang P Kiiza P An assessment of home-based care programs in Uganda: Their strengths and weaknesses. Takemi Working paper Boston, Harvard School of Public Health; 2000.
24. Msobi N Msumi Z HIV/AIDS and other chronic conditions: Home based care cost study, Bagamoyo district-Tanzania: Durban.; 2000.
25. Senyimba C Frame K Harding R A theme issue by, for, and about Africa Br Med J 2005, 331:778-779. 10.1136/bmj.331.7519.778-b
26. Selwyn P Why should we care about palliative care for AIDS in the era of antiretroviral therapy? Sex Transm Infect 2005, 81:2-3. 10.1136/ sti.2004.011585 15681712
27. Harding R Higginson IJ Palliative care in sub-Saharan Africa Lancet 2005, 365:9475-1971. 1977 10.1016/S0140-6736(05)66666-4 15936427
28. Uys L Hensher M The cost of home-based terminal care for people with AIDS in South Africa S Afr Med J 2002, 92(8):624-628. 12244622
29. Sweat M Gregorich S Sangiwa G Furlonge C Balmer D Kamenga C Grinstead O Coates T Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania Lancet 2000, 356(9224):113-121. 10.1016/S0140-6736(00)02447-8 10963247
30. Masobe P Lee T Price M Isoniazide prophylactic therapy for tuberculosis in HIV-seropositive patients--a least-cost analysis S Afr Med J 1995, 85(2):75-81. 7597538
31. Hausler H Sinanovic E Kumaranayake L Naidoo P Schoeman H Karpakis B Godfrey-Faussett P Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa Bull World Health Organ 2006, 84(7):505-588. 10.2471/BLT.04.018606
32. Hansen C Woelk G Jackson H Kerkhoven R Manjonjori N Maramba P Mutambirwa J Ndimande E Vera E The cost of home-based care for HIV/AIDS patients in Zimbabwe AIDS Care 1998, 10(6):751-759. 10.1080/09540129848361 9924529
33. Foster S Godfrey-Faussett P Porter J Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: The example of Zambia AIDS 1997, 11(7):919-925. 10.1097/00002030-199707000-00012 9189218
34. Forsythe S Arthur G Ngatia G Mutemi R Odhiambo J Gilks C Assessing the cost and willingness to pay for voluntary HIV counselling and testing in Kenya Health Policy Plan 2002, 17(2):187-195. 10.1093/heapol/17.2.187 12000779
35. Chandler R Decker C Nziyige B Estimating the cost of providing Home-based Care for HIV/AIDS in Rwanda Bethesda, Partners for Health ReformPlus; 2004.
36. Bell JC Rose DN Sacks HS Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective AIDS 1999, 13(12):1549-1556. 10.1097/00002030-199908200-00016 10465080
37. Aisu T Raviglione MC van Praag E Eriki P Narain JP Barugahare L Tembo G McFarland D Engwau FA Preventive chemotherapy for HIV-associated tuberculosis in Uganda: An operational assessment at a voluntary counselling and testing centre AIDS 1995, 9(3):267-273. 7755915
38. Vassall A Compernolle P Estimating the resource needs of scaling-up HIV/ AIDS and tuberculosis interventions in sub-Saharan Africa: A systematic review for national policy makers and planners Health Policy 2006, 79(1):1-15. 10.1016/j.healthpol.2005.11.005 16388874
39. Dzekedzeke K Prevalence of HIV and Syphilis Zambia Demographic and Health Survey 2001-2002 Calverton, Maryland, USA, Central Statistical Office, Central Board of Health and ORC Macro Central Statistical Office (Zambia), Central Board of Health (Zambia), Macro ORC; 2003.
40. World Health Organisation Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2003 Geneva, World Health Organisation 2003
41. Stringer JS Zulu I Levy J Stringer EM Mwango A Chi BH Mtonga V Reid S Cantrell RA Bulterys M Saag MS Marlink RG Mwinga A Ellerbrock TV Sinkala M Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: Feasibility and early outcomes JAMA 2006/08/15 2006, 296(7):782-793. 10.1001/jama.296.7.782 16905784
42. The United States President's Emergency Plan for AIDS Relief 2007 Country Profile: Zambia http://www.pepfar.gov/press/81694.htm
43. Kumaranayake L Pepperall J Mills A Walker D Costing guidelines for HIV prevention strategies Geneva, UNAIDS; 2000.
44. Economic Research Service ERS International Macroeconomic Data Set - Historical GDP Deflators Economic Research Service, United States Department of Agriculture; 2006.
45. OANDA.com FXHistory: Historical currency exchange rates http://www.oanda.com/convert/fxhistory
46. Weinstein MC Siegel JE Gold MR Kamlet MS Russell LB Recommendations of the Panel on Cost-effectiveness in Health and Medicine JAMA 1996, 276(15):1253-1258. 10.1001/jama.276.15.1253 8849754
47. Drummond M Methods for the Economic Evaluation of Health Care Programmes Oxford, Oxford Medical Publications; 1997.
48. Szakacs TA WD Cameron DW, Clark M, Kocheleff P, Muller FJ, McCarthy AE. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. BMC Infect Dis 2006, 13(6):97. 10.1186/1471-2334-6-97
49. Chu HY CJA Ostermann J, Oenga RB, Itemba DK, Mgonja A, Mtweve S, Bartlett JA, Shao JF, Thielman NM. Sociodemographic and clinical characteristics of clients presenting for HIV voluntary counselling and testing in Moshi, Tanzania. Int J STD AIDS 2005, 16(10):691-696. 10.1258/ 095646205774357307 16212718
50. Kumaranayake L MA Chimzizi R, Hargreaves N, Golombe C, Salaniponi F, Godfrey-Faussett P. Economic Analysis of delivering integrated TB and HIV services: The Malawi ProTEST Project. XV International AIDS Conference Bangkok 2004, TuPeD5214.
51. Shrestha RK Mugisha B Bunnell R Mermin J Hitimana-Lukanika C Odeke R Madra P Adatu F Blandford JM Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda The International Journal of Tuberculosis and Lung Disease 2006, 10:656-662.
52. Kinghorn A Lee T Karstaedt A Khouonane B Sneider H Care of HIV-infected adults at Baragwanath Hospital, Soweto: Part 1. Clinical management and costs of outpatient care. S Afr Med J 1996, 86(11):1484-1489.
53. Kitajima T Kobayashi Y Chiapah W Sato H Chadbunchachai W Thuennadee R Costs of medical services for patients with HIV/AIDS in Khon Kaen, Thailand. AIDS 2003, 17:2375-2381. 10.1097/00002030-200311070-00013 14571190